Pancreatic Cancer Research

ResearcherHarvard UniversityActive in the last 2 years

Jean Wactawski‐Wende

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-3096-9595; OpenAlex author ID A5016111941. Sources: OpenAlex.

Their work

Papers
22 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
30
Papers, trials and grants by year

2012: 1 paper · 2013: 2 papers · 2014: 2 papers · 2015: none · 2016: none · 2017: 1 paper · 2018: none · 2019: 1 paper · 2020: 4 papers · 2021: 2 papers · 2022: 1 paper · 2023: 4 papers · 2024: 1 paper · 2025: 1 paper · 2026: 2 papers

Papers 22

  1. Polygenic scores for risk of pancreatic ductal adenocarcinoma: evaluation of novel and published models. Co-author DOI 10.1038/s41698-026-01479-x↗
  2. Novel Genetic Risk Loci for Pancreatic Ductal Adenocarcinoma Identified in a Genome-wide Study of African Ancestry Individuals Co-author DOI 10.64898/2026.04.21.26351329↗
  3. Allelic effects on KLHL17 expression underlie a pancreatic cancer genome-wide association signal at chr1p36.33. Co-author DOI 10.1038/s41467-025-59109-2↗
  4. Genome-Wide Analysis to Assess if Heavy Alcohol Consumption Modifies the Association between SNPs and Pancreatic Cancer Risk. Co-author DOI 10.1158/1055-9965.epi-24-0096↗
  5. Correction to: Healthy lifestyle index and risk of pancreatic cancer in the Women's Health Initiative. Co-author DOI 10.1007/s10552-023-01754-3↗
  6. Genetic Susceptibility to Nonalcoholic Fatty Liver Disease and Risk for Pancreatic Cancer: Mendelian Randomization. Co-author DOI 10.1158/1055-9965.epi-23-0453↗
  7. Sex-Specific Associations between Adiponectin and Leptin Signaling and Pancreatic Cancer Survival. Co-author DOI 10.1158/1055-9965.epi-23-0505↗
  8. Helicobacter pylori Seropositivity, ABO Blood Type, and Pancreatic Cancer Risk From 5 Prospective Cohorts. Co-author DOI 10.14309/ctg.0000000000000573↗
  9. Healthy lifestyle index and risk of pancreatic cancer in the Women's Health Initiative. Co-author DOI 10.1007/s10552-022-01558-x↗
  10. Hepcidin-regulating iron metabolism genes and pancreatic ductal adenocarcinoma: a pathway analysis of genome-wide association studies. Co-author DOI 10.1093/ajcn/nqab217↗
  11. Smoking Modifies Pancreatic Cancer Risk Loci on 2q21.3. Co-author DOI 10.1158/0008-5472.can-20-3267↗
  12. A Transcriptome-Wide Association Study Identifies Novel Candidate Susceptibility Genes for Pancreatic Cancer. Co-author DOI 10.1093/jnci/djz246↗
  13. Genome-Wide Association Study Data Reveal Genetic Susceptibility to Chronic Inflammatory Intestinal Diseases and Pancreatic Ductal Adenocarcinoma Risk. Co-author DOI 10.1158/0008-5472.can-20-0447↗
  14. Genome-Wide Gene-Diabetes and Gene-Obesity Interaction Scan in 8,255 Cases and 11,900 Controls from PanScan and PanC4 Consortia. Co-author DOI 10.1158/1055-9965.epi-20-0275↗
  15. Mendelian Randomization Analysis of n-6 Polyunsaturated Fatty Acid Levels and Pancreatic Cancer Risk. Co-author DOI 10.1158/1055-9965.epi-20-0651↗
  16. Agnostic Pathway/Gene Set Analysis of Genome-Wide Association Data Identifies Associations for Pancreatic Cancer. Co-author DOI 10.1093/jnci/djy155↗
  17. Low-Dose Aspirin and Pancreatic Cancer Risk-Letter. First author DOI 10.1158/1055-9965.epi-17-0115↗
  18. Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development. Co-author DOI 10.1038/nm.3686↗
  19. Genome-wide association study of survival in patients with pancreatic adenocarcinoma. Co-author DOI 10.1136/gutjnl-2012-303477↗
  20. Polymorphisms in genes related to one-carbon metabolism are not related to pancreatic cancer in PanScan and PanC4. Co-author DOI 10.1007/s10552-012-0138-0↗
  21. An absolute risk model to identify individuals at elevated risk for pancreatic cancer in the general population. Co-author DOI 10.1371/journal.pone.0072311↗
  22. Plasma 25-hydroxyvitamin D and risk of pancreatic cancer. Co-author DOI 10.1158/1055-9965.epi-11-0836↗

Closest collaborators

The 25 strongest of 30 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Fred K. Tabung · 3 shared papers, 2022–2023 · strength 0.48
  2. Thomas E. Rohan · 2 shared papers, 2022–2023 · strength 0.34
  3. Rita Peila · 2 shared papers, 2022–2023 · strength 0.34
  4. Edward L. Giovannucci · 4 shared papers, 2012–2023 · strength 0.33
  5. JoAnn E. Manson · 4 shared papers, 2012–2023 · strength 0.33
  6. Peter Kraft · 4 shared papers, 2012–2023 · strength 0.33
  7. Brian Matthew Wolpin · 4 shared papers, 2012–2023 · strength 0.33
  8. Charles S. Fuchs · 4 shared papers, 2012–2023 · strength 0.33
  9. Chen Yuan · 3 shared papers, 2014–2023 · strength 0.30
  10. Kimmie Ng · 3 shared papers, 2012–2023 · strength 0.30
  11. Ana Babić · 2 shared papers, 2023 · strength 0.28
  12. Jihye Kim · 2 shared papers, 2023 · strength 0.28
  13. Alice A. Lee · 2 shared papers, 2023 · strength 0.28
  14. Qiao-Li Wang · 2 shared papers, 2023 · strength 0.28
  15. Theodore M. Brasky · 1 shared paper, 2017 · strength 0.15
  16. Juhua Luo · 1 shared paper, 2023 · strength 0.14
  17. Jonathan Andrew Nowak · 1 shared paper, 2023 · strength 0.14
  18. Kimberly J. Perez · 1 shared paper, 2023 · strength 0.14
  19. Ying Bao · 2 shared papers, 2012–2014 · strength 0.05
  20. Thales Y. Papagiannakopoulos · 1 shared paper, 2014 · strength 0.03
  21. Douglas Adam Rubinson · 1 shared paper, 2014 · strength 0.03
  22. Annan Yang · 1 shared paper, 2014 · strength 0.03
  23. Jared R. Mayers · 1 shared paper, 2014 · strength 0.03
  24. Zhi Rong Qian · 1 shared paper, 2014 · strength 0.03
  25. Michaël Pollak · 1 shared paper, 2014 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.